A new NIH study suggests that stem-cell transplants may be the next great hope in the fight against multiple sclerosis. According to the study, stem cell transplants of a person’s own blood cells yielded long-term remission of MS symptoms. The treatment is called high-dose immunosuppressive therapy and autologous hematopoietic cell transplant (HDIT/HCT), and the results are astounding. According to the results of the study, after five years of receiving the one-time treatment, 69% of study participants experienced no progression of symptoms, relapse, or new brain lesions.
Although more studies are needed, it appears that this single intervention may be more effective than the MS drugs that are the most commonly prescribed treatment. The study, called HALT-MS, looked at HDIT/HCT in 24 clinical subjects ranging in age 26 to 52, who despite being under treatment for MS were continuing to get worse. The fact that HDIT/HCT was able to help 70% means that it may become a go-to option for those who do not respond to other treatments.
New Jersey-based neurologist and psychiatrist Shiva Gopal Vasishta is on the staff of Kennedy University of Hosptial. Shiva Gopal Vasishta graduated from Government Medical College in Nagpur in 1979 and has been practicing medicine for 40 years. He completed his post-graduate medical education at Boston City Hospital.
Dr. Shiva Gopal Vasishta Vasishta is board certified in neurology and maintains his medical practice in Voorhees, New Jersey. His office accepts Medicare in addition to a number of private insurance providers, such as Aetna and Horizon Blue Cross Blue Shield. He is fluent in both English and Spanish.